Orthobiologics

Aesculap Biologics achieved 50% enrollment in its Phase III clinical trial of NOVOCART® 3D, an autologous chondrocyte transplantation system to treat articular...

Medtronic launched Grafton Demineralized Bone Matrix in Japan for spine and orthopedic procedures. ...

Ortho Regenerative Technologies announced that following a formal meeting with FDA, an IND can be submitted in parallel with completion...

Bone Solutions announced successful implantation in over 500 cases with magnesium-based OsteoCrete® bone void filler....

Seikagaku and Ono Pharmaceutical obtained positive topline results from a Phase III confirmatory study of an HA/NSAID formulation in the treatment...

SIRAKOSS received approval under the CE Mark for Osteo3 nanosynthetic bone graft substitute....

Bioventus launched DUROLANE® single-injection joint fluid osteoarthritis therapy in Malaysia, through exclusive distribution partner Athrotech....

OrthogenRx commenced U.S. launch of TriVisc® sodium hyaluronate for the treatment of knee osteoarthritis pain....

Bioventus introduced OSTEOMATRIX+® biphasic bone graft for orthopaedic and spine applications....

Histogenics plans to evaluate the range of potential strategic alternatives for its NeoCart® cell therapy following FDA's indication that an...